Literature DB >> 19022224

Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.

Carmony L Hartwig1, Andrew S Rosenthal, John D'Angelo, Carol E Griffin, Gary H Posner, Roland A Cooper.   

Abstract

The antimalarial trioxanes, exemplified by the naturally occurring sesquiterpene lactone artemisinin and its semi-synthetic derivatives, contain an endoperoxide pharmacophore that lends tremendous potency against Plasmodium parasites. Despite decades of research, their mechanism of action remains unresolved. A leading model of anti-plasmodial activity hypothesizes that iron-mediated cleavage of the endoperoxide bridge generates cytotoxic drug metabolites capable of damaging cellular macromolecules. To probe the malarial targets of the endoperoxide drugs, we studied the distribution of fluorescent dansyl trioxane derivatives in living, intraerythrocytic-stage Plasmodium falciparum parasites using microscopic imaging. The fluorescent trioxanes rapidly accumulated in parasitized erythrocytes, localizing within digestive vacuole-associated neutral lipid bodies of trophozoites and schizonts, and surrounding the developing merozoite membranes. Artemisinin pre-treatment significantly reduced fluorescent labeling of neutral lipid bodies, while iron chelation increased non-specific cytoplasmic localization. To further explore the effects of endoperoxides on cellular lipids, we used an oxidation-sensitive BODIPY lipid probe to show the presence of artemisinin-induced peroxyl radicals in parasite membranes. Lipid extracts from artemisinin-exposed parasites contained increased amounts of free fatty acids and a novel cholesteryl ester. The cellular accumulation patterns and effects on lipids were entirely endoperoxide-dependent, as inactive dioxolane analogs lacking the endoperoxide moiety failed to label neutral lipid bodies or induce oxidative membrane damage. In the parasite digestive vacuole, neutral lipids closely associate with heme and promote hemozoin formation. We propose that the trioxane artemisinin and its derivatives are activated by heme-iron within the neutral lipid environment where they initiate oxidation reactions that damage parasite membranes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022224      PMCID: PMC2659783          DOI: 10.1016/j.bcp.2008.10.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  63 in total

Review 1.  The biogenesis and functions of lipid bodies in animals, plants and microorganisms.

Authors:  D J Murphy
Journal:  Prog Lipid Res       Date:  2001-09       Impact factor: 16.195

2.  Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model.

Authors:  Jérôme Cazelles; Anne Robert; Bernard Meunier
Journal:  J Org Chem       Date:  2002-02-08       Impact factor: 4.354

Review 3.  Oxysterols: friends, foes, or just fellow passengers?

Authors:  Ingemar Björkhem; Ulf Diczfalusy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a V-type H(+)-ATPase.

Authors:  K J Saliba; K Kirk
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  Carrier-mediated partitioning of artemisinin into Plasmodium falciparum-infected erythrocytes.

Authors:  Nehal Vyas; Bonnie A Avery; Mitchell A Avery; Christy M Wyandt
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).

Authors:  Anne-Catrin Uhlemann; Sergio Wittlin; Hugues Matile; Leyla Y Bustamante; Sanjeev Krishna
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

7.  Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection.

Authors:  S Lauer; J VanWye; T Harrison; H McManus; B U Samuel; N L Hiller; N Mohandas; K Haldar
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

8.  Crystal structure of (-)-mefloquine hydrochloride reveals consistency of configuration with biological activity.

Authors:  Jean M Karle; Isabella L Karle
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Alkylation of heme by the antimalarial drug artemisinin.

Authors:  Anne Robert; Yannick Coppel; Bernard Meunier
Journal:  Chem Commun (Camb)       Date:  2002-03-07       Impact factor: 6.222

10.  Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells.

Authors:  Xiao-Jia Huang; Cheng-Tan Li; Wei-Ping Zhang; Yun-Bi Lu; San-Hua Fang; Er-Qing Wei
Journal:  Pharmacology       Date:  2008-04-11       Impact factor: 2.547

View more
  43 in total

Review 1.  Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum.

Authors:  Connor O'Brien; Philipp P Henrich; Neha Passi; David A Fidock
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

Review 2.  Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.

Authors:  Richard T Eastman; David A Fidock
Journal:  Nat Rev Microbiol       Date:  2009-11-02       Impact factor: 60.633

3.  Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum.

Authors:  Long Cui; Zenglei Wang; Jun Miao; Miao Miao; Ramesh Chandra; Hongying Jiang; Xin-zhuan Su; Liwang Cui
Journal:  Mol Microbiol       Date:  2012-08-06       Impact factor: 3.501

4.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.

Authors:  Nectarios Klonis; Maria P Crespo-Ortiz; Iveta Bottova; Nurhidanatasha Abu-Bakar; Shannon Kenny; Philip J Rosenthal; Leann Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 5.  Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production.

Authors:  Neha Pandey; Shashi Pandey-Rai
Journal:  Protoplasma       Date:  2015-03-27       Impact factor: 3.356

6.  Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite.

Authors:  Sumit S Mahajan; Jiri Gut; Philip J Rosenthal; Adam R Renslo
Journal:  Future Med Chem       Date:  2012-12       Impact factor: 3.808

7.  Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.

Authors:  Matthias A Fügi; Sergio Wittlin; Yuxiang Dong; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

8.  Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.

Authors:  Michael J Delves; Andrea Ruecker; Ursula Straschil; Jöel Lelièvre; Sara Marques; María José López-Barragán; Esperanza Herreros; Robert E Sinden
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 9.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

10.  Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.

Authors:  Sujayita Roy; Arun Kapoor; Fei Zhu; Rupkatha Mukhopadhyay; Ayan Kumar Ghosh; Hyun Lee; Jennifer Mazzone; Gary H Posner; Ravit Arav-Boger
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.